Palvella Therapeutics, Inc. Other Noncash Income (Expense)
Palvella Therapeutics, Inc. (PVLA) reported Other Noncash Income (Expense) of -$864.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2024-11-13
- Palvella Therapeutics, Inc. other noncash income (expense) for the quarter ending 2024-09-30 was -$843.00K, a 4536.84% decline year-over-year.
- Palvella Therapeutics, Inc. other noncash income (expense) for the quarter ending 2024-06-30 was -$26.00K, a 114.29% decline year-over-year.
- Palvella Therapeutics, Inc. other noncash income (expense) for the quarter ending 2024-03-31 was $5.00K.
- Palvella Therapeutics, Inc. other noncash income (expense) for the quarter ending 2023-12-31 was -$5.00K, a 101.63% decline year-over-year.
- Palvella Therapeutics, Inc. other noncash income (expense) for fiscal 2023 was $124.00K, a 36.26% increase from fiscal 2022.
- Palvella Therapeutics, Inc. other noncash income (expense) for fiscal 2022 was $91.00K, a 203.33% increase from fiscal 2021.
- Palvella Therapeutics, Inc. other noncash income (expense) for fiscal 2021 was $30.00K, a 77.44% decline from fiscal 2020.
- Palvella Therapeutics, Inc. other noncash income (expense) for fiscal 2020 was $133.00K, a 92.75% increase from fiscal 2019.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$843.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$869.00K derived: sum of 2 quarters · filed 2024-11-13 | -$864.00K 10-Q · filed 2024-11-13 | -$869.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$21.00K 10-Q · filed 2024-08-14 | -$26.00K derived: sum of 3 quarters · filed 2024-08-14 | -$7.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $5.00K 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $19.00K derived: sum of 3 quarters · filed 2024-11-13 | $201.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $14.00K derived: sum of 2 quarters · filed 2024-11-13 | $196.00K derived: sum of 3 quarters · filed 2024-11-13 | $124.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $201.00K derived: sum of 2 quarters · filed 2024-11-13 | $129.00K 10-Q · filed 2024-11-13 | $436.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $110.00K 10-Q · filed 2024-08-14 | $417.00K derived: sum of 3 quarters · filed 2024-08-14 | $415.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$72.00K 10-Q · filed 2024-05-15 | $235.00K derived: sum of 2 quarters · filed 2024-05-15 | $233.00K derived: sum of 3 quarters · filed 2024-05-15 | $110.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $305.00K derived: sum of 2 quarters · filed 2024-03-29 | $182.00K derived: sum of 3 quarters · filed 2024-03-29 | $91.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$125.00K derived: sum of 2 quarters · filed 2023-11-14 | -$216.00K 10-Q · filed 2023-11-14 | -$160.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$214.00K 10-Q · filed 2023-08-10 | -$158.00K derived: sum of 3 quarters · filed 2023-08-10 | -$198.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$91.00K 10-Q · filed 2023-05-11 | -$35.00K derived: sum of 2 quarters · filed 2023-05-11 | -$75.00K derived: sum of 3 quarters · filed 2023-05-11 | -$102.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $16.00K derived: sum of 2 quarters · filed 2023-03-31 | -$11.00K derived: sum of 3 quarters · filed 2023-03-31 | $30.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$67.00K derived: sum of 2 quarters · filed 2022-11-04 | -$26.00K 10-Q · filed 2022-11-04 | -$186.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $14.00K 10-Q · filed 2022-08-04 | -$146.00K derived: sum of 3 quarters · filed 2022-08-04 | $490.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $41.00K 10-Q · filed 2022-05-11 | -$119.00K derived: sum of 2 quarters · filed 2022-05-11 | $517.00K derived: sum of 3 quarters · filed 2022-05-11 | $274.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $476.00K derived: sum of 2 quarters · filed 2022-03-02 | $233.00K derived: sum of 3 quarters · filed 2022-03-02 | $133.00K 10-K · filed 2022-03-02 |
| 2020-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $393.00K derived: sum of 2 quarters · filed 2021-11-02 | $293.00K 10-Q · filed 2021-11-02 | $452.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$343.00K 10-Q · filed 2021-08-05 | -$184.00K derived: sum of 3 quarters · filed 2021-08-05 | -$425.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$100.00K 10-Q · filed 2021-05-17 | $59.00K derived: sum of 2 quarters · filed 2021-05-17 | -$182.00K derived: sum of 3 quarters · filed 2021-05-17 | -$329.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$82.00K derived: sum of 2 quarters · filed 2021-03-31 | -$229.00K derived: sum of 3 quarters · filed 2021-03-31 | $69.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | -$241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$388.00K derived: sum of 2 quarters · filed 2020-11-04 | -$90.00K 10-Q · filed 2020-11-04 | -$541.00K derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $151.00K 10-Q · filed 2020-08-10 | -$300.00K derived: sum of 3 quarters · filed 2020-08-10 | $130.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $298.00K 10-Q · filed 2020-05-11 | -$153.00K derived: sum of 2 quarters · filed 2020-05-11 | $277.00K derived: sum of 3 quarters · filed 2020-05-11 | $231.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$21.00K derived: sum of 2 quarters · filed 2020-03-13 | -$67.00K derived: sum of 3 quarters · filed 2020-03-13 | -$75.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $384.00K derived: sum of 2 quarters · filed 2019-11-12 | $376.00K 10-Q · filed 2019-11-12 | $170.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$54.00K 10-Q · filed 2019-08-09 | -$260.00K derived: sum of 3 quarters · filed 2019-08-09 | -$324.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$8.00K 10-Q · filed 2019-05-10 | -$214.00K derived: sum of 2 quarters · filed 2019-05-10 | -$278.00K derived: sum of 3 quarters · filed 2019-05-10 | -$301.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$270.00K derived: sum of 2 quarters · filed 2019-03-18 | -$293.00K derived: sum of 3 quarters · filed 2019-03-18 | -$293.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$87.00K derived: sum of 2 quarters · filed 2018-11-07 | -$87.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$23.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | -$49.00K 10-K · filed 2018-03-15 | |||
| 2015-03-31 | $127.48K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |